CRUK Consent Form Publication Update
The CRUK SACT regimen-specific consent form project team is pleased to announce that a number of new consent forms have been published. They are now available on the CRUK website at: www.cruk.org/sact_consent.
Hepatocellular Carcinoma
New forms added for atezolizumab – bevacizumab and lenvatinib.
Renal Cell Carcinoma
New form added for pembrolizumab.
Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.
Best Wishes,
Lucy
Lucy Cox
Cancer Research UK Specialist Pharmacist – Cancer Information Lead
